Azithromycin Dihydrate Tablet, Film Coated
NDC Package 71093-174-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Azithromycin Dihydrate tablets is azithromycin tablet is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. This formulation utilizes a tablet, film coated delivery system. Marketed by Aci Healthcare Usa, Inc., this product is identified by NDC 71093-174 and is authorized under FDA application ANDA215772.

Identification & Billing

NDC Package Code
71093-174-01
Package Description
30 TABLET, FILM COATED in 1 BOTTLE
Product Code
71093-174
11-Digit Billing Format
71093017401
RxNorm Crosswalk
RxCUI: 308460 - azithromycin 250 MG Oral Tablet

Clinical Specifications

Proprietary Name
Azithromycin Dihydrate
Non-Proprietary Name
Azithromycin Dihydrate
Substance Name
Azithromycin Dihydrate
Dosage Form
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
AZITHROMYCIN DIHYDRATE 250 mg/1
Pharmacologic Class
Usage Information
Azithromycin tablet is a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications. [see Dosage and Administration (2)]

Regulatory & Marketing

Labeler Name
Aci Healthcare Usa, Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA215772
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 71093-174-01 identifies a specific commercial package of 30 tablet, film coated in 1 bottle of Azithromycin Dihydrate, a human prescription drug labeled by Aci Healthcare Usa, Inc.. This tablet, film coated is formulated for oral use and contains azithromycin dihydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Aci Healthcare Usa, Inc. on December 01, 2022. The current certification is valid through December 31, 2026.

How is this Aci Healthcare Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 71093017401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
71093-174-01
11-Digit CMS (5-4-2)
71093-0174-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.